title: Blinded by the light: molecular imaging in pancreatic adenocarcinoma.
abstract: The early detection and optimal perisurgical management of pancreatic adenocarcinoma are paramount goals in our quest to increase cure rates in this lethal malignancy. Molecular imaging techniques may be the conduit through which new genomic and proteomic discoveries about this disease are brought to the clinic.
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, California, USA. mtempero@medicine.ucsf.edu
authors.forename: Eric
authors.initials: E
authors.lastname: Collisson
authors.forename: Margaret
authors.initials: M
authors.lastname: Tempero
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis*; D014408:Biomarkers, Tumor / Q000032:analysis; D003952:Diagnostic Imaging; D055088:Early Detection of Cancer; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis*; D051190:Plectin / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; C495332:PLEC protein, human; D051190:Plectin